A study led by Maddalena Ardissino and colleagues examined the characteristics and clinical outcomes of patients with congenital heart disease (CHD) who received mechanical circulatory support (MCS) across Europe. Utilizing data from the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) from 2011 to 2023, the study analyzed 5340 participants, separating adult and pediatric…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest